Cargando…

Inflammation Amplification by Versican: The First Mediator

The effects of inflammation may not always benefit the individual. Its amplifying nature represents a highly regulated biological program, and the inflammatory microenvironment is its essential component. Growing evidence suggests that the ECM (extracellular matrix) is important for the early steps...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhenwei, Miao, Lei, Wang, Lianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397501/
https://www.ncbi.nlm.nih.gov/pubmed/22837669
http://dx.doi.org/10.3390/ijms13066873
_version_ 1782238192881106944
author Zhang, Zhenwei
Miao, Lei
Wang, Lianghua
author_facet Zhang, Zhenwei
Miao, Lei
Wang, Lianghua
author_sort Zhang, Zhenwei
collection PubMed
description The effects of inflammation may not always benefit the individual. Its amplifying nature represents a highly regulated biological program, and the inflammatory microenvironment is its essential component. Growing evidence suggests that the ECM (extracellular matrix) is important for the early steps of inflammation. Versican, a ubiquitous component of the ECM, contributes to the formation of the inflammatory response and is highly regulated by cytokines. Certain cytokines exert their initial effects on versican to alter the homeostasis of the inflammatory milieu, and inappropriate production of versican may promote the next inflammatory response. Therefore, versican could be the first step in the amplification of the inflammatory response, and ongoing research of this molecule may help to explain the pathogenesis of inflammation.
format Online
Article
Text
id pubmed-3397501
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-33975012012-07-26 Inflammation Amplification by Versican: The First Mediator Zhang, Zhenwei Miao, Lei Wang, Lianghua Int J Mol Sci Opinion The effects of inflammation may not always benefit the individual. Its amplifying nature represents a highly regulated biological program, and the inflammatory microenvironment is its essential component. Growing evidence suggests that the ECM (extracellular matrix) is important for the early steps of inflammation. Versican, a ubiquitous component of the ECM, contributes to the formation of the inflammatory response and is highly regulated by cytokines. Certain cytokines exert their initial effects on versican to alter the homeostasis of the inflammatory milieu, and inappropriate production of versican may promote the next inflammatory response. Therefore, versican could be the first step in the amplification of the inflammatory response, and ongoing research of this molecule may help to explain the pathogenesis of inflammation. Molecular Diversity Preservation International (MDPI) 2012-06-06 /pmc/articles/PMC3397501/ /pubmed/22837669 http://dx.doi.org/10.3390/ijms13066873 Text en © 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Opinion
Zhang, Zhenwei
Miao, Lei
Wang, Lianghua
Inflammation Amplification by Versican: The First Mediator
title Inflammation Amplification by Versican: The First Mediator
title_full Inflammation Amplification by Versican: The First Mediator
title_fullStr Inflammation Amplification by Versican: The First Mediator
title_full_unstemmed Inflammation Amplification by Versican: The First Mediator
title_short Inflammation Amplification by Versican: The First Mediator
title_sort inflammation amplification by versican: the first mediator
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397501/
https://www.ncbi.nlm.nih.gov/pubmed/22837669
http://dx.doi.org/10.3390/ijms13066873
work_keys_str_mv AT zhangzhenwei inflammationamplificationbyversicanthefirstmediator
AT miaolei inflammationamplificationbyversicanthefirstmediator
AT wanglianghua inflammationamplificationbyversicanthefirstmediator